Japanese SPF sends message that it is more than just a patent assertion entity with new drug discovery collaboration

IP Bridge (IPB) – the company that operates Japan’s sovereign patent fund (SPF) – announced last week that it has signed a drug discovery deal with Kyushu University, indicating that it is aiming beyond straight monetisation activities to fulfil its…

Get unlimited access to all IAM content